GGrantIndex
← Leaderboards

Meyeon Park

University Of California, San Francisco

$3,628,220
Attributed
$7,530,996
Total exposure
4
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201125
$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,530,996 · 4

By mechanism

R01$3,938,930 · 1
U01$2,553,646 · 1
K23$927,732 · 1
F32$110,688 · 1

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Kidney

Research focus

KidneyChronic Kidney FailureHigh RiskRenal FunctionEvaluationKidney DiseasesPersonsBiometryFollow-UpGenotypeAfrican AmericanEnrollmentLiving DonorsGeneticAmericanRisk VariantApolipoproteinsMedical CenterKidney TransplantationCaliforniaRegistriesGenesSan FranciscoUniversities

Grant awards (23)

12/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$300,000
U01 · FY2025 · DK
12/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$340,000
U01 · FY2024 · DK
Living Donor Extended Time Outcomes (LETO) Study$500,750
R01 · FY2023 · DK
12/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$370,129
U01 · FY2023 · DK
Living Donor Extended Time Outcomes (LETO) Study$564,733
R01 · FY2022 · DK
(1/1) Maximizing geographic and scientific reach through a Northern California APOLLO Network: application for Clinical Center$306,451
U01 · FY2022 · DK
(1/1) Maximizing geographic and scientific reach through a Northern California APOLLO Network: application for Clinical Center$125,089
U01 · FY2022 · DK
Living Donor Extended Time Outcomes (LETO) Study$674,973
R01 · FY2021 · DK
Living Donor Extended Time Outcomes (LETO) Study$844,088
R01 · FY2020 · DK
Living Donor Extended Time Outcomes (LETO) Study$630,615
R01 · FY2020 · DK
(1/1) Maximizing geographic and scientific reach through a Northern California APOLLO Network: application for Clinical Center$133,333
U01 · FY2020 · DK
Living Donor Extended Time Outcomes (LETO) Study$723,771
R01 · FY2019 · DK
(1/1) Maximizing geographic and scientific reach through a Northern California APOLLO Network: application for Clinical Center$346,144
U01 · FY2019 · DK
(1/1) Maximizing geographic and scientific reach through a Northern California APOLLO Network: application for Clinical Center$269,853
U01 · FY2018 · DK
(1/1) Maximizing geographic and scientific reach through a Northern California APOLLO Network: application for Clinical Center$84,826
U01 · FY2018 · DK
(1/1) Maximizing geographic and scientific reach through a Northern California APOLLO Network: application for Clinical Center$277,821
U01 · FY2017 · DK
Why do patients with cardiovascular disease develop kidney injury and disease?$198,882
K23 · FY2017 · DK · contact PI
Why do patients with cardiovascular disease develop kidney injury and disease?$182,161
K23 · FY2016 · DK · contact PI
Why do patients with cardiovascular disease develop kidney injury and disease?$182,304
K23 · FY2015 · DK · contact PI
Why do patients with cardiovascular disease develop kidney injury and disease?$182,241
K23 · FY2014 · DK · contact PI
Why do patients with cardiovascular disease develop kidney injury and disease?$182,144
K23 · FY2013 · DK · contact PI
Subclinical and clinical heart disease and the effect on kidney injury and diseas$42,238
F32 · FY2013 · DK · contact PI
Subclinical and clinical heart disease and the effect on kidney injury and diseas$68,450
F32 · FY2011 · DK · contact PI